Original Source(s)
Related Content
Ivarmacitinib Eased Refractory PCA: Case Report
Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.
May 20, 2026
-
4 min
Guselkumab Shows Psoriasis Benefit in Darker Skin Tones
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026
-
3 min
Medical Oddities: Ancient Practice Calms Modern BP
Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.
by Teraya Smith
May 13, 2026
-
5 min